Harvard T.H. Chan School of Public Health

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD (2024) DeFilipp Z, Kim HT, Spyrou N, Katsivelos N, Kowalyk S, Eng G, Kasikis S, et al. Journal article Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions (2024) Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, et al. Journal article A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry (2023) Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, Michailidou K, et al. Journal article A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2 (2023) Zanti M, O'Mahony DG, Parsons MT, Li H, Dennis J, Aittomäkkiki K, Andrulis IL, et al. Journal article Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery (2023) Phung MT, Webb PM, DeFazio A, Fereday S, Lee AW, Bowtell DD, Fasching P, et al. Journal article Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study (2021) Yola IM, Moser C, Duncan MS, Schwedhelm E, Atzler D, Maas R, Hannemann J, et al. Journal article Associations between genetically predicted circulating protein concentrations and endometrial cancer risk (2021) Zhu J, O’mara TA, Liu D, Setiawan VW, Glubb D, Spurdle AB, Fasching P, et al. Journal article Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021) Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Culver H, Arndt V, et al. Journal article Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2021) Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, et al. Journal article Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al. Journal article